causal

Formulary Tiers Steer Patients to Expensive Drugs

The formulary—a health plan's tiered list (often 5, sometimes 7 tiers) determining whether and at what level a drug is reimbursed—has become a tool by which PBMs and drug companies steer patients toward more expensive drugs, because a high-volume drug company can offer better rebate deals in exchange for excluding or disadvantaging rival drugs on the menu.

causalpending

Speaker

Robin Feldman

Evidence Quote

“The name of the game in this is: volume. So, a drug company that has a lot of volume with a particular PBM... can offer a better deal in exchange for excluding rival drugs from the formula.”

Source

Robin Feldman on Drugs, Money, and Secret Handshakes— EconTalk
Created: 6/13/2026, 12:12:41 AM

Your notes

Loading notes...